AKT1 and cancer: Furthermore, Akt is dephosphorylated at Thr308 (converting it into the inactive form) at reduced levels of intracellular reactive oxygen species (ROS) [23], making SOD an attractive therapeutic agent for sensitizing cancer cells to TRAIL-induced apoptosis.